Menetrier's disease. A diagnostic and therapeutic challenge
- PMID: 34137712
Menetrier's disease. A diagnostic and therapeutic challenge
Abstract
We present a rare case of hypertrophic gastropathy associated with protein loss. A 35-year-old man was hospitalized for bowel habit changes, abdominal pain, generalized edema and symptomatic anemia. Pertinent laboratory findings included iron deficiency anemia (Hb 6.7g/dl, ferritin 5 ng/ml) and marked hypoalbuminemia (albumin 2.5 g/dl). Endoscopic biopsy samples of giant gastric folds observed along the greater gastric curvature revealed foveolar hyperplasia and significant parietal cell loss. Endoscopic ultrasonography showed gastric parietal thickening with preserved architecture and normal gastric wall layers. Menetrier disease was diagnosed and the patient treated with cetuximab, a monoclonal antibody that inhibits ligand binding of transforming growth factor alpha (TGFa), preventing gastric mucosa cell proliferation. After twelve months of treatment, the patient referred symptoms improvement, and gastric biopsy levels of the proliferation marker protein Ki-67 had decreased.
Presentamos un caso infrecuente de gastropatía hipertrófica asociada a pérdida de proteínas. Un hombre de 35 años fue hospitalizado por cambios en los hábitos intestinales, dolor abdominal, edema generalizado y anemia sintomática. Los hallazgos de laboratorio pertinentes incluyeron anemia ferropénica (Hb 6.7 g/dl, ferritina 5 ng/ml) e hipoalbuminemia marcada (albúmina 2.5 g/dl). Las muestras de biopsia endoscópica de pliegues gástricos gigantes observados a lo largo de la curvatura mayor gástrica revelaron hiperplasia foveolar y pérdida significativa de células parietales. La ecografía endoscópica mostró engrosamiento parietal gástrico con arquitectura conservada y capas de pared gástrica normales. Se diagnosticó enfermedad de Menetrier y se trató al paciente con cetuximab, un anticuerpo monoclonal que inhibe la unión del ligando del factor de crecimiento transformante alfa (TGFa), evitando la proliferación de células de la mucosa gástrica. Después de doce meses de tratamiento, el paciente refirió mejoría de los síntomas y los niveles de la proteína marcadora de proliferación Ki-67 en biopsia gástrica habían disminuido.
Keywords: Menetrier's disease; cetuximab; hypertrophic gastropathy.
Similar articles
-
Ménétrier's disease of the stomach: a clinical challenge.Curr Gastroenterol Rep. 2011 Dec;13(6):513-7. doi: 10.1007/s11894-011-0222-8. Curr Gastroenterol Rep. 2011. PMID: 21931998 Review.
-
Ménétrier's disease : a case of successful treatment using long-acting octreotide.Acta Gastroenterol Belg. 2019 Jul-Sep;82(3):429-432. Acta Gastroenterol Belg. 2019. PMID: 31566332
-
Ménétrier-like disease in a Pointer with concurrent granulomatous gastritis, helicobacteriosis and leishmaniosis: a case report.BMC Vet Res. 2021 Mar 2;17(1):98. doi: 10.1186/s12917-021-02802-3. BMC Vet Res. 2021. PMID: 33653341 Free PMC article.
-
[Ménétrier's disease--a rare cause of a protein deficiency syndrome].Dtsch Med Wochenschr. 1992 Apr 3;117(14):531-4. doi: 10.1055/s-2008-1062343. Dtsch Med Wochenschr. 1992. PMID: 1555500 German.
-
Menetrier's disease associated with Helicobacter pylori: three cases with sonographic findings and a literature review.Ann Trop Paediatr. 2011;31(2):141-7. doi: 10.1179/146532811X13006353133876. Ann Trop Paediatr. 2011. PMID: 21575319 Review.
Cited by
-
Upper gastrointestinal bleeding as an unusual manifestation of localized Ménétrier's disease with an underlying lipoma: A case report.World J Gastrointest Endosc. 2023 Jan 16;15(1):10-18. doi: 10.4253/wjge.v15.i1.10. World J Gastrointest Endosc. 2023. PMID: 36686066 Free PMC article.
-
Ménétrier's disease in a patient with refractory ulcerative colitis: a clinical challenge and review of the literature.BMJ Case Rep. 2021 Oct 19;14(10):e246137. doi: 10.1136/bcr-2021-246137. BMJ Case Rep. 2021. PMID: 34667052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
